MENU
+Compare
ONCO
Stock ticker: NASDAQ
AS OF
Apr 23 closing price
Price
$0.07
Change
+$0.01 (+16.67%)
Capitalization
959.98K

ONCO Onconetix Inc Forecast, Technical & Fundamental Analysis

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health and oncology... Show more

ONCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ONCO with price predictions
Apr 22, 2025

ONCO in -8.89% downward trend, declining for three consecutive days on April 21, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ONCO declined for three days, in of 274 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for ONCO entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ONCO just turned positive on March 20, 2025. Looking at past instances where ONCO's MACD turned positive, the stock continued to rise in of 21 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where ONCO advanced for three days, in of 108 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.028) is normal, around the industry mean (13.887). P/E Ratio (0.000) is within average values for comparable stocks, (63.180). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.782). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.026) is also within normal values, averaging (251.479).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ONCO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONCO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ONCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ONCO is expected to report earnings to rise 10.53% to -20 cents per share on March 07

Onconetix Inc ONCO Stock Earnings Reports
Q4'23
Est.
$-0.21
Q3'23
Est.
$-0.19
Q2'23
Missed
by $0.06
Q1'23
Beat
by $0.02
Q4'22
Beat
by $0.05
The last earnings report on November 09 showed earnings per share of -18 cents, meeting the estimate of -18 cents. With 7.65M shares outstanding, the current market capitalization sits at 959.98K.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 East Fifth Street
Phone
+1 513 620-4101
Employees
12
Web
https://www.onconetix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLVX1.860.08
+4.21%
HilleVax
BWXT104.642.33
+2.28%
BWX Technologies
KURA6.370.06
+0.95%
Kura Oncology
MBINM25.60-0.01
-0.06%
Merchants Bancorp
AMPH23.54-0.39
-1.63%
Amphastar Pharmaceuticals

ONCO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCO has been loosely correlated with INO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCO jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCO
1D Price
Change %
ONCO100%
+9.39%
INO - ONCO
50%
Loosely correlated
+3.93%
IKNA - ONCO
35%
Loosely correlated
+4.39%
PCSA - ONCO
35%
Loosely correlated
+0.27%
APM - ONCO
26%
Poorly correlated
+6.14%
ADVM - ONCO
25%
Poorly correlated
+8.42%
More